Described herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medications, such units which include a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with really reduced permeability to ox